Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$178K Hold
5,677
﹤0.01% 2289
2025
Q4
$151K Hold
5,677
﹤0.01% 2409
2025
Q3
$219K Buy
5,677
+377
+7% +$11.7K ﹤0.01% 2269
2025
Q2
$134K Buy
5,300
+929
+21% +$22.3K ﹤0.01% 2396
2025
Q1
$87.1K Hold
4,371
﹤0.01% 2587
2024
Q4
$115K Hold
4,371
﹤0.01% 2563
2024
Q3
$116K Hold
4,371
﹤0.01% 2570
2024
Q2
$104K Buy
4,371
+411
+10% +$10.3K ﹤0.01% 2589
2024
Q1
$95.2K Buy
+3,960
New +$88.7K ﹤0.01% 2559
2023
Q4
Sell
-3,915
Closed -$55.2K 2869
2023
Q3
$55.2K Hold
3,915
﹤0.01% 2817
2023
Q2
$74K Buy
+3,915
New +$73.4K ﹤0.01% 2832

Other funds holding XOMA

MetLife Investment Management's XOMA Position: Q1 2026 in Review

MetLife Investment Management held its Xoma (XOMA) position steady in Q1 2026 at 5,677 shares worth $178K. The position accounts for ﹤0.01% of the portfolio, ranked #2289.

MetLife Investment Management first reported a position in XOMA in Q2 2023 and has held it in 11 quarters since. The position peaked at $219K in Q3 2025. 85 funds tracked by Wall St. Rank hold XOMA as of Q1 2026.

  • MetLife Investment Management held 5,677 shares of Xoma worth $178K as of Q1 2026.
  • MetLife Investment Management left its Xoma share count unchanged in Q1 2026.
  • Xoma made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2289 holding.
  • MetLife Investment Management first reported a position in Xoma in Q2 2023 and has held it in 11 quarters since.
  • MetLife Investment Management's Xoma position peaked at $219K in Q3 2025.
  • 85 funds tracked by Wall St. Rank held Xoma as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.